Deutsche Bank’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.6M | Buy |
73,847
+11,195
| +18% | +$242K | ﹤0.01% | 1906 |
|
|
2025
Q4 | $1.49M | Buy |
62,652
+14,316
| +30% | +$292K | ﹤0.01% | 1962 |
|
|
2025
Q3 | $657K | Buy |
48,336
+6,763
| +16% | +$70.3K | ﹤0.01% | 2411 |
|
|
2025
Q2 | $338K | Sell |
41,573
-4,480
| -10% | -$38.3K | ﹤0.01% | 2660 |
|
|
2025
Q1 | $362K | Sell |
46,053
-4,165
| -8% | -$48.3K | ﹤0.01% | 2655 |
|
|
2024
Q4 | $748K | Buy |
50,218
+15,995
| +47% | +$261K | ﹤0.01% | 2400 |
|
|
2024
Q3 | $523K | Buy |
34,223
+7,557
| +28% | +$119K | ﹤0.01% | 2428 |
|
|
2024
Q2 | $406K | Sell |
26,666
-1,637
| -6% | -$26.4K | ﹤0.01% | 2431 |
|
|
2024
Q1 | $534K | Buy |
28,303
+86
| +0.3% | +$1.49K | ﹤0.01% | 2320 |
|
|
2023
Q4 | $539K | Buy |
28,217
+1,363
| +5% | +$21.8K | ﹤0.01% | 2352 |
|
|
2023
Q3 | $482K | Buy |
26,854
+3,380
| +14% | +$67.9K | ﹤0.01% | 2197 |
|
|
2023
Q2 | $477K | Sell |
23,474
-11,032
| -32% | -$210K | ﹤0.01% | 2402 |
|
|
2023
Q1 | $629K | Sell |
34,506
-18,247
| -35% | -$349K | ﹤0.01% | 2363 |
|
|
2022
Q4 | $1.09M | Sell |
52,753
-149,412
| -74% | -$4.11M | ﹤0.01% | 2002 |
|
|
2022
Q3 | $5.29M | Sell |
202,165
-5,166
| -2% | -$137K | ﹤0.01% | 1187 |
|
|
2022
Q2 | $5.25M | Buy |
207,331
+6,195
| +3% | +$152K | ﹤0.01% | 1256 |
|
|
2022
Q1 | $6.35M | Sell |
201,136
-2,357
| -1% | -$79K | ﹤0.01% | 1290 |
|
|
2021
Q4 | $8.24M | Buy |
203,493
+992
| +0.5% | +$38.5K | ﹤0.01% | 1191 |
|
|
2021
Q3 | $7.06M | Sell |
202,501
-29,637
| -13% | -$922K | ﹤0.01% | 1321 |
|
|
2021
Q2 | $6.38M | Buy |
232,138
+96,200
| +71% | +$2.75M | ﹤0.01% | 1391 |
|
|
2021
Q1 | $3.82M | Buy |
135,938
+100,345
| +282% | +$3.49M | ﹤0.01% | 1713 |
|
|
2020
Q4 | $925K | Buy |
35,593
+9,697
| +37% | +$235K | ﹤0.01% | 2496 |
|
|
2020
Q3 | $443K | Sell |
25,896
-18,745
| -42% | -$419K | ﹤0.01% | 2712 |
|
|
2020
Q2 | $1.1M | Buy |
44,641
+25,626
| +135% | +$692K | ﹤0.01% | 2152 |
|
|
2020
Q1 | $264K | Sell |
19,015
-12,559
| -40% | -$156K | ﹤0.01% | 2813 |
|
|
2019
Q4 | $318K | Sell |
31,574
-17,451
| -36% | -$147K | ﹤0.01% | 2962 |
|
|
2019
Q3 | $445K | Buy |
49,025
+11,756
| +32% | +$94.5K | ﹤0.01% | 2735 |
|
|
2019
Q2 | $294K | Sell |
37,269
-2,094
| -5% | -$21K | ﹤0.01% | 3616 |
|
|
2019
Q1 | $490K | Sell |
39,363
-1,623
| -4% | -$17.6K | ﹤0.01% | 3467 |
|
|
2018
Q4 | $439K | Buy |
40,986
+19,919
| +95% | +$233K | ﹤0.01% | 3435 |
|
|
2018
Q3 | $293K | Buy |
21,067
+10,986
| +109% | +$140K | ﹤0.01% | 4060 |
|
|
2018
Q2 | $124K | Buy |
+10,081
| New | +$158K | ﹤0.01% | 4469 |
|
Other funds holding RCUS
GS
SCM
VPM
VCM
WP
SL
Deutsche Bank's RCUS Position: Q1 2026 in Review
Deutsche Bank increased its Arcus Biosciences (RCUS) stake by 18% in Q1 2026, buying an estimated $242K and bringing the position to 73,847 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1906.
Deutsche Bank first reported a position in RCUS in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.24M in Q4 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.
- Deutsche Bank held 73,847 shares of Arcus Biosciences worth $1.6M as of Q1 2026.
- Deutsche Bank bought 11,195 Arcus Biosciences shares in Q1 2026, an estimated $242K.
- Arcus Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1906 holding.
- Deutsche Bank first reported a position in Arcus Biosciences in Q2 2018 and has held it in 32 quarters since.
- Deutsche Bank's Arcus Biosciences position peaked at $8.24M in Q4 2021.
- 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.